Trial Condition(s):

Hypertension

Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment (SONAR)

Bayer Identifier:

14010

ClinicalTrials.gov Identifier:

NCT00932867

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment

Inclusion Criteria
- Patients over 18 years of age
 - Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
 - Patients, who do not tolerate ACE inhibitors (must be documented in the official ambulant documentation)

Inclusion criteria for the control arm (treated by ACEi):
 - Patients over 18 years of age
 - Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
 - Patients, who tolerate ACEi treatment
Exclusion Criteria
- Cholestasis, severe hepatic insufficiency 
 - Allergy to telmisartan
 - Gravidity or lactation 

Exclusion criteria for the arm of patient treated by ACEi:
 - Cholestasis, severe hepatic insufficiency 
 - Allergy to ACEi
 - Gravidity or lactation

Trial Summary

Enrollment Goal
3114
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Kinzal/Pritor (Telmisartan, BAY68-9291)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Location, Slovakia

Status
Completed
 
Locations

Investigative Site

Many Locations, Romania

Status
Completed
 

Trial Design